SCG Cell Therapy
SCG Cell Therapy goal is to prevent and treat cancer by using the immune system of the patient to target pathogenic infections.
Operating in biotechnology, life science based in Asia-Pacific (APAC), Association of Southeast Asian Nations (ASEAN), Southeast Asia, SCG Cell Therapy was founded in 2017.
Its activity falls under biotechnology, life science; the profile below is assembled from public directory data.
The business is associated with Asia-Pacific (APAC), Association of Southeast Asian Nations (ASEAN), Southeast Asia.
Its current recorded stage is Series_C.
The company reports a headcount in the c_00051_00100 range.
Public records show total funding of about $8.1M.
| Sector | Biotechnology, Life Science |
|---|---|
| Headquarters | Asia-Pacific (APAC), Association of Southeast Asian Nations (ASEAN), Southeast Asia |
| Founded | 2017 |
| Employees | c_00051_00100 |
| Stage | series_c |
| Total funding | $8,100,000 |
Website: www.scgcell.com
Sign in to view the contact information we hold for SCG Cell Therapy.
Create a free account
Create a free account